This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...
The Trade Desk just fell to a multi-year low, sparking a debate between momentum fans and value hunters. This guide b...
Foreign R&D drives innovation across borders, but it carries subtle tax costs that can eat into profits. This guide e...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
Lucid Group has faced a tough year, with its stock down dramatically. This article breaks down the reasons behind the...
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
TONX reported healthy momentum in Q1 2026, but the real story lies in its growth engine. This article breaks down th...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
SoundHoundAI is riding an AI surge, but profits lag behind growth. This stock analysis breaks down where the company ...
AI stocks are on fire, yet one AI stock has fallen 24.27% from its recent high. This guide explains why the rally has...